Walleye Trading LLC Cara Therapeutics, Inc. Transaction History

Walleye Trading LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$7.45 - $13.84 $76,049 - $141,278	-10,208 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$9.94 - $12.65 $101,467 - $129,131	10,208 New	10,208 $124,000
Q2 2020 Aug 14, 2020	SELL	$12.39 - $17.33 $72,531 - $101,449	-5,854 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$9.12 - $17.78 $61,569 - $120,032	-6,751 Reduced 53.56%	5,854 $77,000
Q4 2018 Feb 14, 2019	BUY	$12.45 - $23.47 $156,932 - $295,839	12,605 New	12,605 $164,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $16.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.